Testing effectiveness (Phase 2)Study completedNCT03406962
What this trial is testing
MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Who this might be right for
Inherited Metabolic Disorders (IMD)
Magenta Therapeutics, Inc. 8